Using Mupirocin and Xeroform Together for Wound Management
Rationale for Combined Use
- Mupirocin is a topical antibiotic with excellent activity against Staphylococcus aureus (including MRSA) and Streptococcus species, which are common causes of skin infections 1
- Mupirocin 2% ointment is indicated for the topical treatment of impetigo and other localized skin infections caused by susceptible strains of S. aureus and S. pyogenes 1
Application Method
- Apply mupirocin 2% ointment directly to the wound bed first, then cover with xeroform gauze as the primary dressing 2, 3
Clinical Evidence Supporting Efficacy
- For minor skin infections such as impetigo and secondarily infected skin lesions, mupirocin 2% topical ointment is specifically recommended in clinical practice guidelines by the Infectious Diseases Society of America 2, 4
Potential Benefits of Combination
- Mupirocin provides antimicrobial activity while xeroform offers protection of the wound bed 4, absorption of exudate 2, and maintenance of a moist healing environment 3
Precautions and Limitations
- If the wound shows signs of worsening infection despite treatment, reassess and consider systemic antibiotics, as recommended by the Infectious Diseases Society of America 3
- For abscesses, incision and drainage remains the primary treatment, with topical or systemic antibiotics as adjunctive therapy, according to the Infectious Diseases Society of America guidelines 2